NO942274L - 2-piperazinon-forbindelser og deres anvendelse - Google Patents

2-piperazinon-forbindelser og deres anvendelse

Info

Publication number
NO942274L
NO942274L NO942274A NO942274A NO942274L NO 942274 L NO942274 L NO 942274L NO 942274 A NO942274 A NO 942274A NO 942274 A NO942274 A NO 942274A NO 942274 L NO942274 L NO 942274L
Authority
NO
Norway
Prior art keywords
group
groups
stands
agent
formula
Prior art date
Application number
NO942274A
Other languages
English (en)
Norwegian (no)
Other versions
NO942274D0 (no
Inventor
Hirosada Sugihara
Zenichi Terashita
Hideto Fukushi
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO942274D0 publication Critical patent/NO942274D0/no
Publication of NO942274L publication Critical patent/NO942274L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
NO942274A 1993-06-17 1994-06-16 2-piperazinon-forbindelser og deres anvendelse NO942274L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14613693 1993-06-17
JP25414293 1993-10-21

Publications (2)

Publication Number Publication Date
NO942274D0 NO942274D0 (no) 1994-06-16
NO942274L true NO942274L (no) 1994-12-19

Family

ID=26477044

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942274A NO942274L (no) 1993-06-17 1994-06-16 2-piperazinon-forbindelser og deres anvendelse

Country Status (11)

Country Link
US (1) US5550131A (de)
EP (1) EP0643072B1 (de)
KR (1) KR950000683A (de)
CN (1) CN1098409A (de)
AT (1) ATE176912T1 (de)
AU (1) AU6477194A (de)
CA (1) CA2126026A1 (de)
DE (1) DE69416629T2 (de)
FI (1) FI942881A7 (de)
HU (1) HUT70045A (de)
NO (1) NO942274L (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935963A (en) * 1995-04-26 1999-08-10 Takeda Chemical Industries, Ltd Piperazinones, their production and use
CA2180206A1 (en) * 1995-06-30 1996-12-31 Motoya Ohshika Freeze-dried preparation for pharmaceutical use
MX9801716A (es) 1995-08-30 1998-05-31 Searle & Co Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina.
US6100423A (en) * 1995-08-30 2000-08-08 G. D. Searle & Co. Amino benzenepropanoic acid compounds and derivatives thereof
US5919777A (en) * 1996-04-24 1999-07-06 Novo Nordisk A/S Compounds with growth hormone releasing properties
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
AU6120298A (en) 1997-03-07 1998-09-22 Takeda Chemical Industries Ltd. 2-peperazinone-1-acetic acid derivatives and their use
AU728006B2 (en) * 1997-03-24 2001-01-04 Merck & Co., Inc. Thrombin inhibitors
US6133256A (en) * 1997-04-14 2000-10-17 Cor Therapeutics Inc Selective factor Xa inhibitors
US6369063B1 (en) 1997-04-14 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
EP0977772A1 (de) 1997-04-14 2000-02-09 Cor Therapeutics, Inc. Selektive faktor xa-inhibitoren
US6333321B1 (en) 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
EP1082324A4 (de) * 1998-05-26 2002-01-02 Merck & Co Inc Imidazopyridinverbindungen als thrombininhibitoren
CA2380218A1 (en) * 1999-07-26 2001-02-01 Santen Pharmaceutical Co., Ltd. Novel thiazine or pyrazine derivatives
KR100360122B1 (ko) * 2000-09-14 2002-11-07 대한민국(서울대학교 총장) 제충 및 제초 기능을 갖는 폴리에틸렌 멀칭필름
US7718802B2 (en) 2001-08-10 2010-05-18 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
US7655658B2 (en) * 2001-08-10 2010-02-02 Palatin Technologies, Inc. Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
US7456184B2 (en) * 2003-05-01 2008-11-25 Palatin Technologies Inc. Melanocortin receptor-specific compounds
US7732451B2 (en) * 2001-08-10 2010-06-08 Palatin Technologies, Inc. Naphthalene-containing melanocortin receptor-specific small molecule
WO2003013571A1 (en) 2001-08-10 2003-02-20 Palatin Technologies, Inc. Peptidomimetics of biologically active metallopeptides
US7354923B2 (en) * 2001-08-10 2008-04-08 Palatin Technologies, Inc. Piperazine melanocortin-specific compounds
US7968548B2 (en) 2003-05-01 2011-06-28 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine compounds with diamine groups
US7727991B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Substituted melanocortin receptor-specific single acyl piperazine compounds
US7727990B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine and keto-piperazine compounds
US7709484B1 (en) 2004-04-19 2010-05-04 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
US7834017B2 (en) 2006-08-11 2010-11-16 Palatin Technologies, Inc. Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA39849C2 (uk) * 1991-03-26 2001-07-16 Ф.Хоффманн-Ля Рош Аг ПОХІДНІ N-АЦИЛ-<font face="Symbol">a</font>-АМІНОКИСЛОТИ АБО ЇХ ФІЗІОЛОГІЧНО ПРИЙНЯТНІ СОЛІ, ПРОСТІ АБО СКЛАДНІ ЕФІРИ, АМІДИ АБО ЇХ ГІДРАТИ ЯК ФАРМАЦЕВТИЧНО АКТИВНІ РЕЧОВИНИ
AU646966B2 (en) * 1991-08-23 1994-03-10 Takeda Chemical Industries Ltd. 2-piperazinone compounds, their production and use

Also Published As

Publication number Publication date
AU6477194A (en) 1994-12-22
CN1098409A (zh) 1995-02-08
CA2126026A1 (en) 1994-12-18
FI942881A7 (fi) 1994-12-18
DE69416629T2 (de) 1999-07-22
NO942274D0 (no) 1994-06-16
ATE176912T1 (de) 1999-03-15
HUT70045A (en) 1995-09-28
FI942881A0 (fi) 1994-06-16
US5550131A (en) 1996-08-27
DE69416629D1 (de) 1999-04-01
KR950000683A (ko) 1995-01-03
EP0643072A1 (de) 1995-03-15
EP0643072B1 (de) 1999-02-24
HU9401726D0 (en) 1994-09-28

Similar Documents

Publication Publication Date Title
NO942274D0 (no) 2-piperazinon-forbindelser og deres anvendelse
TW341573B (en) New erythromycin derivatives, their preparation process and their use as medicaments
TW200700397A (en) Novel hsp90 inhibitor
EP2053041A3 (de) 1,3,5-Trisubstituierte 2(1H)-Pyridone als AMPA-Rezeptor-Hemmer verwendbar zur Behandlung von zB Parkinson-Krankheit
NO972909L (no) Substituerte azetidin-2-oner for behandling av atherosklerose
YU19002A (sh) Derivati hinolil-propil-piperidina, njihovo dobivanje i smeše koje ih sadrže
ATE250590T1 (de) Neuartiger p2x 7 rezeptor-antagonisten zur verwendung in der behandlung von entzündlichen, immuninduzierten erkrankungen oder erkrankungen des herz-kreislauf-systems
BG105190A (en) Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
NO941101L (no) Quinazolin-derivater
NO20051411L (no) Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk bruk derav samt intermediater til fremstilling derav
EP1338595A3 (de) Xanthin-Derivate als DPP-IV-Inhibitoren
NO20040961L (no) Antitumoranaloger
NO985294L (no) Kontrastmidler
NO992770L (no) Nye heterocyklisk substituerte benzamider og deres anvendelse ved bekjempelse av sykdommer
DE69514823D1 (de) Polyanionische benzyl-glykosiden als inhibitoren zur glatten-muskelzellen-proliferation
CA2110806A1 (en) 4-(1h-pyrrol-1-yl)imidazoles with angiotensin ii antagonist activity
DE69925472D1 (de) Benzoheterocyclische distamycinderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
MY118004A (en) Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
MY120248A (en) Water soluble azoles as broad-spectrum antifungals
CA2099591A1 (en) 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3- carboxylic acid compounds useful as antibacterial agents
AU670675B2 (en) Morpholine derivative
HUP9800820A2 (hu) Halogén-alk(en)il-tio-szubsztituenseket tartalmazó szulfonil-amino-karbonil-triazolinon-származékok, intermedierjeik, előállításuk és alkalmazásuk, a vegyületeket hatóanyagként tartalmazó herbicid vagy fungicid készítmények
HUP9900679A2 (hu) Simaizom sejtburjánzást gátló benzimidazolszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
DE69818051D1 (de) N-benzenesulfonyl-l-prolin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
DE69725167D1 (de) N-benzolsulfonyl-l-prolin derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung